Delayed bleeding after implant surgery in patients taking novel oral anticoagulants: a case report.
10.17245/jdapm.2017.17.2.143
- Author:
Chihun KIM
1
;
Chugeum DAM
;
Jieun JEONG
;
Eun Jung KWAK
;
Wonse PARK
Author Information
1. Department of Advanced General Dentistry, Yonsei University, Seoul, Korea. wonse@yuhs.ac
- Publication Type:Case Report
- Keywords:
Anticoagulants;
Bleeding;
Dental Implants;
Emergencies;
Rivaroxaban
- MeSH:
Aged;
Anticoagulants*;
Atrial Fibrillation;
Dental Implants;
Drug Interactions;
Emergencies;
Hematologic Tests;
Hemorrhage*;
Humans;
Male;
Rivaroxaban;
Thrombosis;
Warfarin
- From:Journal of Dental Anesthesia and Pain Medicine
2017;17(2):143-147
- CountryRepublic of Korea
- Language:English
-
Abstract:
The use of novel oral anticoagulants (NOACs) has increased in recent times in an effort to overcome the shortcomings of warfarin. They are being used primarily for the prevention of thrombosis caused by atrial fibrillation and offer the advantages of having fewer drug interactions than warfarin, no dietary restrictions, and no requirement for regular blood tests. Although there is reportedly less postoperative bleeding even if the drug is not discontinued during procedures that can cause local bleeding, such as dental procedures, no well-designed clinical studies have assessed postoperative bleeding associated with the use of these drugs. This article reports a case of a 74-year-old male patient who was taking rivaroxaban. The patient underwent a dental implant procedure after discontinuing rivaroxaban for one day and subsequently suffered delayed bleeding on postoperative day 6. Accordingly, this article also reports that the use of NOACs may also lead to delayed bleeding.
